Companies · Other Health Care

Wavetec Vision Systems Inc

Aliso Viejo · Other Health Care

Diligence memoA one-page analyst read on Wavetec Vision Systems Inc — recommendation, valuation, rhythm, risks.
$99.9M
Total raised · real
12
Rounds
3.9×
Latest step-up
Top 5%
Sector rank · raised
Series B
Latest stage · inferred · Fri Feb 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)

Wavetec Vision Systems Inc looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.14× the median modeled value of Series B Other Health Care companies in 2013–2015 (85 peers) — value vs value, same stage and era.
Dormant
  • Last raise 12.3 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Wavetec Vision Systems Inc is one of 5377 Other Health Care companies tracked from Aliso Viejo. By capital raised it ranks among the largest (ahead of 96% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeries B · 2009-01-29 Raised $20M (real) Modeled valuation $445M (est)Series B2009Series B · 2010-07-08 Raised $6.0M (real) Modeled valuation $133M (est)Series B2010Series B · 2011-01-07 Raised $3.5M (real) Modeled valuation $78M (est)Series B2011Series B · 2011-04-29 Raised $16M (real) Modeled valuation $353M (est)Series B2011Series B · 2012-02-01 Raised $1.5M (real) Modeled valuation $33M (est)Series B2012Series B · 2012-03-27 Raised $16M (real) Modeled valuation $348M (est)Series B2012Series B · 2012-03-27 Raised $17M (real) Modeled valuation $366M (est)Series B2012Series B · 2013-02-01 Raised $2.0M (real) Modeled valuation $44M (est)Series B2013Series B · 2013-02-01 Raised $4.0M (real) Modeled valuation $89M (est)Series B2013Series B · 2013-02-01 Raised $11M (real) Modeled valuation $244M (est)Series B2013Series B · 2014-02-06 Raised $750K (real) Modeled valuation $17M (est)Series B2014Series B · 2014-02-28 Raised $2.9M (real) Modeled valuation $64M (est)Series B2014Cumulative $100M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$20.1M · 2009
Series B extension$6.0M · 2010
Series B extension$3.5M · 2011
Series B extension$15.9M · 2011
Series B extension$1.5M · 2012
Series B extension$15.7M · 2012
Series B extension$16.5M · 2012
Series B extension$2.0M · 2013
Series B extension$4.0M · 2013
Series B extension$11.0M · 2013
Series B extension$750K · 2014
Series B extension$2.9M · 2014

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 25%.

Modeled valuation trajectory
$64.1M
Base estimate est.
$6.8M
Conservative case
$246.7M
Upside case
$16.1M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series B · modeled $445.0M · 2009-01-292009Series B · modeled $132.9M · 2010-07-08Series B · modeled $77.5M · 2011-01-07Series B · modeled $352.7M · 2011-04-29Series B · modeled $33.2M · 2012-02-01Series B · modeled $347.8M · 2012-03-27Series B · modeled $365.5M · 2012-03-27Series B · modeled $44.3M · 2013-02-01Series B · modeled $88.6M · 2013-02-01Series B · modeled $243.7M · 2013-02-01Series B · modeled $16.6M · 2014-02-06Series B · modeled $64.1M · 2014-02-282014
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
6.0 yr
Elapsed time used
12.3 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
6 mo
Avg between rounds
$19.7M/yr
Capital velocity
17.4 yr
On record since
2009
First round
12
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 41× above median
This company$99.9M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.2× of median
This company$2.9M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 2.9× above median
This company$64.1M
Sector median$22.1M

Raised more than 96% of sector peers (real $). Modeled value above 71% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #80 of 85.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Drynachan, Llc · Series B Raised $40.0M · modeled $886.2M (est)Vistria SHC Holdings, LLC · Series B Raised $39.7M · modeled $879.5M (est)Ebh Holding Company, Inc. · Series B Raised $70.9M · modeled $871.1M (est)Orthopediatrics Corp · Series B Raised $57.5M · modeled $864.0M (est)Assurerx Health, Inc · Series B Raised $51.5M · modeled $828.4M (est)IMRIS Inc. · Series B Raised $36.8M · modeled $816.0M (est)Remedy Partners, Inc. · Series B Raised $56.4M · modeled $795.3M (est)Hansen Medical Inc · Series B Raised $126.0M · modeled $775.4M (est)BCOM Investment Partners, LLC · Series B Raised $34.5M · modeled $764.3M (est)Michigan Critical Care Consultants, Inc. · Series B Raised $34.0M · modeled $753.2M (est)HY Holdings, Inc. · Series B Raised $33.0M · modeled $731.1M (est)Medical Solutions L.L.C. · Series B Raised $32.5M · modeled $720.0M (est)Wavetec Vision Systems Inc (this company) Raised $99.9M · modeled $64.1M (est)Wavetec Vision Systems Inc
CompanyStageRaised · realValue · estvs peer med.
Drynachan, LlcSeries B$40.0M$886.2M2.00×
Vistria SHC Holdings, LLCSeries B$39.7M$879.5M1.99×
Ebh Holding Company, Inc.Series B$70.9M$871.1M1.97×
Orthopediatrics CorpSeries B$57.5M$864.0M1.95×
Assurerx Health, IncSeries B$51.5M$828.4M1.87×
IMRIS Inc.Series B$36.8M$816.0M1.84×
Remedy Partners, Inc.Series B$56.4M$795.3M1.79×
Hansen Medical IncSeries B$126.0M$775.4M1.75×
BCOM Investment Partners, LLCSeries B$34.5M$764.3M1.72×
Michigan Critical Care Consultants, Inc.Series B$34.0M$753.2M1.70×
HY Holdings, Inc.Series B$33.0M$731.1M1.65×
Medical Solutions L.L.C.Series B$32.5M$720.0M1.62×
Wavetec Vision Systems Inc this companySeries B$99.9M$64.1M0.14×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$20.1M2009-01-29$111.6M$445.0M90%
Series B$6.0M2010-07-08$33.3M$132.9M90%
Series B$3.5M2011-01-07$19.4M$77.5M90%
Series B$15.9M2011-04-29$88.4M$352.7M90%
Series B$1.5M2012-02-01$8.3M$33.2M90%
Series B$15.7M2012-03-27$87.2M$347.8M90%
Series B$16.5M2012-03-27$91.7M$365.5M90%
Series B$2.0M2013-02-01$11.1M$44.3M90%
Series B$4.0M2013-02-01$22.2M$88.6M90%
Series B$11.0M2013-02-01$61.1M$243.7M90%
Series B$750K2014-02-06$4.2M$16.6M90%
Series B$2.9M2014-02-28$16.1M$64.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$20.1M2009-01-29
    • First recorded raise — entered as Series B.
  2. Series B$6.0M2010-07-08
    • Raised 17 mo later, in step with the ~14 mo sector norm.
    • Round 3.3× smaller than the prior — bridge or down round.
  3. Series B$3.5M2011-01-07
    • Came back fast: 6 mo vs the ~14 mo sector norm.
    • Round 1.7× smaller than the prior — bridge or down round.
  4. Series B$15.9M2011-04-29
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 4.5× larger than the prior — scaling up.
  5. Series B$1.5M2012-02-01
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round 10.6× smaller than the prior — bridge or down round.
  6. Series B$15.7M2012-03-27
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 10.5× larger than the prior — scaling up.
  7. Series B$16.5M2012-03-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  8. Series B$2.0M2013-02-01
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round 8.3× smaller than the prior — bridge or down round.
  9. Series B$4.0M2013-02-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.0× larger than the prior — scaling up.
  10. Series B$11.0M2013-02-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.8× larger than the prior — scaling up.
  11. Series B$750K2014-02-06
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 14.7× smaller than the prior — bridge or down round.
  12. Series B$2.9M2014-02-28
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 3.9× larger than the prior — scaling up.
Intelligence
2014 ~Q3
Modeled next raise · ~6mo cadence
$8.7M
Modeled next size est.range $5.6M$13.9M
3.9×
Last step-up
$19.7M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Bruce Feuchter11 other2010-07
Anthony Lando5 other2014-02
Gerard Van Hamel Platerink5 other2013-02
James Tananbaum5 other2013-02
Bryant Fong4 other2014-02
Charles Warden4 other2009-01
Joe Mandato4 other2009-01
Scott Cooper4 other2009-01
Chris Calcaterra1 other2009-01
Steve Waite1 other2009-01
Thomas Berryman1 other2009-01
Thomas Frinzi1 other2011-01
Ken Aldrich2010-07
Kenneth Aldrich2009-01
Richard Lindstrom, M.D.2010-07
Victor Hebert2013-02
Registry & provenance

Wavetec Vision Systems Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1402824
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Sebacia, Inc.Other Health CareSeries B$71.2M$221.5Mnetwork1 shared operator · same sector · same stage
Augmedix, Inc.Other Health CareSeries B$67.9M$113.2Mnetwork1 shared operator · same sector · same stage
Ceterix Orthopaedics, Inc.Other Health CareSeries B$54.4M$510.5Mnetwork1 shared operator · same sector · same stage
Scanadu IncOther Health CareSeries B$44.7M$71.9Mnetwork1 shared operator · same sector · same stage
MedAvail, Inc.Other Health CareSeries C$97.0M$2.0Bnetwork1 shared operator · same sector
AliveCor, Inc.Other Health CareSeries C$105.9M$1.2Bnetwork1 shared operator · same sector
ViaLase, Inc.Other Health CareSeries C$84.1M$395.9Mnetwork1 shared operator · same sector
Halscion IncBiotechnologySeries A$13.8M$155.4Mnetwork3 shared operators
Frequently asked
How much funding has Wavetec Vision Systems Inc raised?
Wavetec Vision Systems Inc has raised approximately $99.9M in disclosed capital across 12 recorded financing rounds, aggregated from public filings.
What is Wavetec Vision Systems Inc's estimated valuation?
Provath's modeled valuation for Wavetec Vision Systems Inc is approximately $64.1M (modeled range $6.8M–$246.7M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Wavetec Vision Systems Inc at?
Wavetec Vision Systems Inc's latest modeled financing stage is Series B. Its most recent recorded round closed around Fri Feb 28.
What does Wavetec Vision Systems Inc do and where is it based?
Wavetec Vision Systems Inc operates in the Other Health Care sector, based in Aliso Viejo.
Explore related

See where Wavetec Vision Systems Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Wavetec Vision Systems Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.